15.3 C
London
Friday, October 18, 2024
HomeTagsLEQEMBI

Tag: LEQEMBI

spot_imgspot_img

LEQEMBI Wins Best New Drug And Clinical Advance of The Year at The Scrip Awards 2023

Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that Alzheimer’s disease (AD) treatment LEQEMBI® (lecanemab-irmb) was awarded both the Best New Drug...

Japan – LEQEMBI (lecanemab-Irmb) Named One of Time’s Best Inventions of 2023

Eisai Co. Ltd. announced today that TIME has selected Alzheimer’s disease (AD) treatment LEQEMBI® (lecanemab-irmb) as one of THE BEST INVENTIONS of 2023 in...

Japan – “LEQEMBI Intravenous Infusion” (Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Japan

Eisai Co., Ltd. and Biogen Inc. announced today that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody “LEQEMBI® Intravenous Infusion” (200 mg, 500mg, lecanemab)...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img